EXPERIENCE IN THE MANAGEMENT OF OCCLUSIVE DEEP VENUS THROMBOSIS WITH ENOXAPARININ SODIUM IN OUTPATIENT SETTINGS

Abstract

The article presents the experience in management of occlusive deep vein thrombosis with enoxaparin sodium in outpatient settings. The study included two groups of patients: the patients of the first group received unfractionated heparin for 10-14 days, followed by the treatment of patients with vitamin K antagonists (warfarin), and the patients of the second group also received enoxaparin sodium for 1 month with subsequent treatment with vitamin K antagonists. The study showed that the use of enoxaparin for the period of 1 month in combination with vitamin K antagonists significantly improved the results of treatment of these patients. It was also found that the use of enoxaparin sodium increased neither the risk of hemorrhagic complications nor the risk of thrombocytopenia.

Keywords

• occlusive deep veins thrombosis
• enoxaparin sodium
• antagonists of vitamin k